Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/30271
Title: | Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice | Authors: | DEWACHTER, Ilse Reversé, Delphine Caluwaerts, Nathalie Ris, Laurence Kuipéri, Cuno Van den Haute, Chris Spittaels, Kurt Umans, Lieve Serneels, Lutgarde Thiry, Els Moechars, Dieder Mercken, Mark Godaux, Emile Van Leuven, Fred |
Issue Date: | 2002 | Publisher: | SOC NEUROSCIENCE | Abstract: | In the brain of Alzheimer's disease (AD) patients, neurotoxic amyloid peptides accumulate and are deposited as senile plaques. A major therapeutic strategy aims to decrease production of amyloid peptides by inhibition of gamma-secretase. Presenilins are polytopic transmembrane proteins that are essential for gamma-secretase activity during development and in amyloid production. By loxP/Cre-recombinase-mediated deletion, we generated mice with postnatal, neuron-specific presenilin-1 (PS1) deficiency, denoted PS1(n-/-), that were viable and fertile, with normal brain morphology. In adult PS1(n-/-) mice, levels of endogenous brain amyloid peptides were strongly decreased, concomitant with accumulation of amyloid precursor protein (APP) C-terminal fragments. In the cross of APP[V717I]xPS1 (n-/-) double transgenic mice, the neuronal absence of PS1 effectively prevented amyloid pathology, even in mice that were 18 months old. This contrasted sharply with APP[V717I] single transgenic mice that all develop amyloid pathology at the age of 10-12 months. In APP[V717I]xPS1 (n-/-) mice, long-term potentiation (LTP) was practically rescued at the end of the 2 hr observation period, again contrasting sharply with the strongly impaired LTP in APP[V717I] mice. The findings demonstrate the critical involvement of amyloid peptides in defective LTP in APP transgenic mice. Although these data open perspectives for therapy of AD by gamma-secretase inhibition, the neuronal absence of PS1 failed to rescue the cognitive defect, assessed by the object recognition test, of the parent APP[V717I] transgenic mice. This points to potentially detrimental effects of accumulating APP C99 fragments and demands further study of the consequences of inhibition of gamma-secretase activity. In addition, our data highlight the complex functional relation of APP and PS1 to cognition and neuronal plasticity in adult and aging brain. | Keywords: | PS1;Alzheimer’s disease;neuronal plasticity;cognition;amyloid pathology;mouse model | Document URI: | http://hdl.handle.net/1942/30271 | ISSN: | 0270-6474 | e-ISSN: | 1529-2401 | ISI #: | 000175296200022 | Rights: | 2002 Society for Neuroscience | Category: | A1 | Type: | Research Report |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
3445.full.pdf | 461.66 kB | Adobe PDF | View/Open |
SCOPUSTM
Citations
224
checked on Oct 8, 2025
WEB OF SCIENCETM
Citations
211
checked on Oct 9, 2025
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.